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Abstract
Background: Enteric pathogens have developed mechanisms to disrupt tight junctions and increase gut
permeability. Many studies have analysed the ability of live probiotics to protect intestinal epithelial cells against
tight junction damage caused by bacterial pathogens. Escherichia coli Nissle 1917 (EcN) is among the probiotics that
positively modulates the intestinal epithelial barrier by regulating expression and distribution of tight junction
proteins. We previously reported that regulation of ZO-1, claudin-14 and claudin-2 is mediated by EcN secreted
factors, either free-released or associated with outer membrane vesicles (OMVs). Factors secreted by commensal
ECOR63 elicited comparable effects in intact epithelial T-84 and Caco-2 cell monolayers.
Results: Here we analyse the ability of OMVs and soluble secreted factors to protect epithelial barrier function in
polarized T-84 and Caco-2 cells infected with enteropathogenic Escherichia coli (EPEC). Transepithelial electrical resistance,
paracellular permeability, mRNA levels and subcellular distribution of tight junction proteins were monitored in the
absence or presence of EcN and ECOR63 extracellular fractions. EPEC downregulated expression of ZO-1 ZO-2, occludin
and claudin-14 and altered the subcellular localization of ZO-1, occludin and F-actin cytoskeleton. OMVs and soluble
factors secreted by EcN and ECOR63 counteracted EPEC-altered transepithelial resistance and paracellular permeability,
preserved occludin and claudin-14 mRNA levels, retained ZO-1 and occludin at tight junctions in the cell boundaries and
ameliorated F-actin disorganization. Redistribution of ZO-1 was not accompanied by changes at mRNA level.
Conclusion: This study provides new insights on the role of microbiota secreted factors on the modulation of intestinal
tight junctions, expanding their barrier-protective effects against pathogen-induced disruption.
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Background
The intestinal epithelium constitutes a physical and bio-
chemical barrier that limits translocation of luminal mi-
crobes, antigens, and toxins into host tissues. Several
mechanisms are involved in this protective function, in-
cluding production of an extracellular mucin layer, se-
cretion of antimicrobial peptides and the formation of
intercellular tight junctions that seal the epithelial layer
against the luminal content, while preserving and con-
trolling the passage of small ions and water-soluble sol-
utes through the paracellular space. The intestinal
epithelium is also crucial to orchestrate host immune re-
sponses to microbiota-derived signals [1, 2].
Adjacent epithelial cells are joined by several types of
intercellular connections that include tight junctions (TJs),
adherens junctions (AJs), and desmosomes. TJs are in the
apical part of the polarized epithelium and regulate the
paracellular permeability of the epithelial monolayer,
whereas AJs and desmosomes fulfil intercellular communi-
cation functions [1]. TJs are formed by several types of
transmembrane proteins such as occludin, claudins, junc-
tional adhesion molecules and tricellulin, as well as cyto-
solic scaffold proteins such as zonula occludens (ZO)
proteins (ZO-1, ZO-2 and ZO-3), which in turn anchor the
integral membrane proteins to the actin cytoskeleton. This
bridging is essential for maintaining TJ barrier integrity [3,
4]. TJs are highly dynamic structures controlled by a great
variety of signaling pathways in response to multiple stimuli
that regulate the expression and/or subcellular location of
TJ proteins. The regulatory mechanisms include transcrip-
tional control, membrane trafficking, and post-translational
modifications that determine the ability of TJ proteins to
establish specific protein-protein interactions [5–8].
Disruption of gut epithelial TJs results in enhanced intes-
tinal permeability, a condition that positively correlates with
a wide variety of diseases [9]. Enteric pathogens such as en-
teropathogenic Escherichia coli (EPEC) have evolved strat-
egies to disrupt TJ structures as a mechanism for
increasing gut permeability and helping their dissemination
into the host tissues [8]. EPEC is a non-invasive pathogen
whose virulence depends on a T3SS secretion system that
inject virulence factors and effector proteins directly into
the cytoplasm of the infected cell [10]. Translocated bacter-
ial effectors alter functions of the target cells by different
mechanisms, which involve modulation of cell signalling
pathways and changes in the architecture of cellular struc-
tures such as the actin cytoskeleton, the microtubule net-
work that directs vesicle trafficking, or connections
between TJ proteins. An intricate combination of bacterial
factors leads to the formation of attaching and effacing le-
sions on the gut mucosa, a characteristic feature of EPEC
infection. Effectors such as EspF, Map and NleA contribute
to TJ disruption [11, 12]. The subsequent alteration of para-
cellular permeability of the intestinal epithelium is one of
the EPEC-mediated effects, which eventually leads to diar-
rhea [9, 12, 13].
Barrier disruption caused by enteric pathogens can be
prevented or counteracted by certain probiotics and gut
beneficial microbes [14–17]. One example is the pro-
biotic Escherichia coli Nissle 1917 (EcN) with proven ef-
fectiveness in the treatment of inflammatory intestinal
disorders [18–20] and acute diarrhea [21]. The EcN gen-
ome encodes a great variety of interference and fitness
factors that enhance EcN survival in the gut (healthy or
inflamed) and play an important role in the beneficial ef-
fects of this probiotic [22]. There is wide scientific evi-
dence that EcN has immunomodulatory effects, mainly
due to its ability to trigger activation/inactivation mech-
anisms of the immune response that lead to a positive
balance between pro- and anti-inflammatory local cyto-
kines [22, 23]. In addition, EcN positively modulates the
intestinal epithelial barrier by triggering upregulation
and redistribution of the TJ proteins ZO-1, ZO-2 and
claudin-14 [24–26].
To identify the EcN factors that mediate regulation of
TJs, our group was focused on the study of bacterial se-
creted factors, which can easily diffuse through the
mucin layer before reaching intestinal epithelial cells [27,
28]. Nowadays, membrane vesicles secreted by gut bac-
teria are considered relevant players in microbiota-host
interaction, as they allow long distance delivery of mi-
crobial effectors directly to the host [29]. We showed
that outer membrane vesicles (OMVs) released by the
probiotic EcN and the commensal ECOR63 are taken up
by intestinal epithelial cells [30] and modulate the epi-
thelial barrier integrity through several mechanisms. In
T-84 and Caco-2 cell monolayers, vesicles from these
strains reinforce TJs through activation of ZO-1 and
claudin-14 expression, downregulation of the leaky pro-
tein claudin-2 and modulation of ZO-1 subcellular dis-
tribution. Free-secreted factors also contribute to this
regulation [31]. In addition, EcN OMVs induce IL-22 ex-
pression in human colonic explants [32]. IL-22 acts on
epithelial cells and enhances the protective function of
the intestinal barrier by inducing the expression of
mucin and antimicrobial proteins. In a murine model of
experimental colitis, oral administration of EcN OMVs
counteract the altered expression of pro-inflammatory
cytokines and markers of intestinal barrier function such
as Trefoil factor-3 (TFF3) [33]. This pleiotropic peptide
mediates protection and repair of the epithelium by sev-
eral mechanisms that include redistribution of ZO-1 to
intercellular junctions [34, 35].
Based on previous studies showing that the barrier
function of epithelial cell monolayers was strengthened
by EcN and ECOR63 OMVs and free-secreted factors
[31], here we evaluate the barrier protective effects of
these extracellular fractions in a cellular model of
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epithelial barrier damaged by EPEC infection. The re-
sponse was assessed through transepithelial electrical re-
sistance (TER) and paracellular permeability assays,
expression analysis of TJ proteins by RT-qPCR, and ana-
lysis of F-actin and TJ protein redistribution by confocal
fluorescence microscopy.
Results
Membrane vesicles and soluble factors secreted by EcN
and ECOR63 prevent EPEC-mediated epithelial barrier
disruption in T-84 and Caco-2 cell monolayers
Previous studies of our group showed that cell-free su-
pernatants collected from EcN cultures prevent disrup-
tion of Caco-2 monolayers caused by EPEC infection
[36]. Therefore, the protective effect was attributed to
secreted factors. Cell-free supernatants contain all the
factors secreted by bacteria, either released through
membrane vesicles (OMVs) or in a free-soluble form
(COF-SN). As both soluble and vesicle-associated factors
secreted by the probiotic EcN and the commensal
ECOR63 can strengthen the epithelial barrier in cellular
models that mimic the normal intestinal epithelium [31],
we sought to test whether these extracellular fractions
could protect against EPEC-induced damage in polarized
intestinal epithelial cells. Epithelial barrier function was
analysed by measuring TER and FD-4 flux as markers of
epithelial resistance and permeability, respectively. To
this end, Caco-2 and T-84 cell monolayers grown in
Transwell membrane supports were infected with EPEC
E2348/69 (MOI 100) for 3 h. In parallel, cell monolayers
were infected with EPEC in the presence of OMVs (0.1
mg/ml) or COF-SN (0.5 mg/ml) obtained from DMEM
cultures of EcN and ECOR63 strains. The concentration
of both extracellular samples was selected according to
previous dose-response curves. The same amounts were
used in previous studies on intact cell monolayers [31].
Fig. 1 OMVs and free-soluble factors (COF-SN) secreted by EcN and ECOR63 maintain barrier function in EPEC-infected cells. Confluent T-84 and
Caco-2 cell monolayers grown in Transwell supports were infected with EPEC (MOI of 100) for 3 h in the absence or presence of EcN or ECOR63
OMVs (0.1 mg/ml) or COF-SN (0.5 mg/ml). Non-treated cells were processed in parallel as a control. Epithelial barrier function was analysed by
measuring TER (a) and FD-4 flux (b) as markers of epithelial resistance and barrier permeability. a TER values were measured before and after 3-h
infection. Data are presented as percentage of changes in TER (decrease) from the initial value. b After 3-h infection, cell monolayers were
washed and treated apically with FD-4 (1 mg/ml). The fluorescence in the basolateral chamber was measured before and 1 h after the addition of
FD-4. FD-4 flux values were calculated by subtracting the fluorescence intensity units (FI) measured at 0 h. Data were expressed as fold-change
compared with non-infected control cells, whose values were normalized as 1. In all panels, data are from three independent biological
experiments performed in triplicate. The TER baseline control values were 1290 ± 98Ω.cm2 for T-84 monolayers and around 920 ± 80Ω.cm2 for
Caco-2 cells. a, Significance against untreated control cells (p≤ 0.05); b, significance against control EPEC-infected cells (p ≤ 0.05)
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Untreated cell monolayers were used as a control. EPEC
infection significantly reduced the TER values of polar-
ized cell monolayers compared to untreated control
cells. However, simultaneous apical stimulation with
COF-SN or OMVs from both microbiota strains neutral-
ized the decrease in TER caused by EPEC, with TER
values that did not significantly differ from those of non-
infected control cells (Fig. 1a).
To examine whether OMVs and COF-SN isolated
from EcN and ECOR63 also counteracted EPEC-induced
increased paracellular permeability, the transport of the
paracellular marker FD-4 was measured in T-84 and
Caco-2 monolayers challenged by EPEC infection. In
both cell lines, the unidirectional flux of FD-4 was sig-
nificantly higher in cell monolayers incubated with EPEC
than in controls. When cells were infected in the pres-
ence of EcN or ECOR63 extracellular fractions, there
was a significant decrease in FD-4 flux with values close
to those of the non-treated control cells (Fig. 1b).
The implication of the ERK pathway in the modulation
of barrier integrity mediated by these bacterial extracel-
lular fractions was evaluated in T-84 monolayers treated
with the specific ERK 1/2 inhibitor U0126 (25 μM). After
15 min pre-treatment, T-84 cells were incubated with
EPEC (MOI 100) alone or simultaneously with OMVs or
COF-SN, and TER was measured at 3 h. In the presence
of the inhibitor U0126, EcN and ECOR63 secreted frac-
tions were unable to compensate for the decrease in
TER caused by EPEC (Fig. 2a). The protective effect of
all secreted fractions was virtually lost by ERK 1/2 inhib-
ition, except for ECOR63-derived COF-SN. In this case,
a tendency to neutralize the drop in TER was observed,
although values did not reach statistical significance
(Fig. 2a). These results indicate that the reinforcement of
the epithelial barrier promoted by EcN and ECOR63 se-
creted factors depends, at least in part, on ERK 1/2 sig-
nalling. The regulatory effects were not restricted to
conditions of damaged epithelial barrier. In fact, parallel
Fig. 2 Analysis of host and bacterial factors involved in the strengthening activity of EcN and ECOR63 secreted fractions. The strengthening
activity of COF-SN and OMVs depends on the ERK1/2 signalling pathway both in EPEC-infected cells (a) and intact cell monolayers (b). a-b Before
infection/stimulation with OMVs or COF-SN, T-84 cell monolayers were pre-treated for 15 min with the ERK1/2 inhibitor U0126 (25 μM). TER values
were measured before and after 3-h treatment. c-d Effect of heat treatment on the strengthening activity of EcN and ECOR63 COF-SN. EPEC-
infected (c) or intact (d) T-84 cell monolayers were incubated with heated COF-SN (h-COF-SN), and TER values were measured before and after 3-
h treatment. In all panels, data are presented as percentage of changes in TER from the initial value from three independent biological
experiments performed in triplicate. TER initial values were between 1100 and 1300Ω.cm2. a, Significance against untreated control cells (p≤
0.02); b, significance against control EPEC-infected cells (a, c) or cells treated with EcN or ECOR63 control extracellular fractions (b, d) (p≤ 0.05)
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experiments performed in T-84 cells that were not chal-
lenged by EPEC infection showed that inhibition of ERK
1/2 activity also abolishes the ability of EcN and
ECOR63 extracellular fractions to increase the TER of
the cell monolayers (Fig. 2b). Again, under conditions of
intact epithelial barrier ERK 1/2 inhibition only resulted
in partial loss of the strengthening activity of COF-SN
from ECOR63.
To discover the nature of the free-soluble secreted fac-
tors that prevent EPEC-mediated reduction of TER, COF-
SN were heat-inactivated before being added to the apical
compartment of T-84 monolayers. As shown in Fig. 2c,
heat treatment abolished the protective activity of EcN su-
pernatants as the TER values did not differ significantly
from those of single EPEC-infected cells. In contrast, the
protective effect of ECOR63 COF-SN was preserved after
heat inactivation. In the presence of heated ECOR63
COF-SN, EPEC-infected cells displayed TER values like
those of control cells. Proteinase K treatment of EcN and
ECOR63 COF-SN yielded results that were comparable
with those obtained by heat inactivation (not shown).
Overall, these results suggested that a protein factor medi-
ates the protective activity of EcN COF-SN, whereas other
factors of a different nature might contribute in the case
of the ECOR63 supernatant. These effects were confirmed
in experiments performed in non-infected T-84 mono-
layers incubated with heat-inactivated supernatants.
Again, heat treatment completely abolished the strength-
ening activity of EcN COF-SN on intact cell monolayers
but partially preserved the activity of the ECOR63 super-
natant fraction (Fig. 2d).
Effect of OMVs and soluble factors secreted by EcN and
ECOR63 on the expression of TJ proteins in T-84 cell
monolayers challenged by EPEC infection
The prevention of TER reduction in EPEC-infected epi-
thelial cells by OMVs and COF-SN from EcN and
ECOR63 pointed to counteracting changes in TJ proteins.
First, we undertook RT-qPCR analyses to assess whether
the protection mediated by these bacterial fractions corre-
lated with changes in the expression of relevant TJ-
proteins known to be regulated by EcN and ECOR63 se-
creted fractions under intact barrier conditions, such as
ZO-1, claudin-14 and claudin-2 [31], or dysregulated by
EPEC infection, such as occludin and claudin-1 [16].
For this, T-84 monolayers (9 days post-confluence)
were infected with EPEC (MOI 100) for 3 h in the ab-
sence or presence of OMVs or COF-SN. Untreated T-84
monolayers were processed as a control. The relative
mRNA levels of TJ proteins were measured by RT-
qPCR, using the β-actin gene as a reference (Fig. 3).
EPEC infection significantly decreases mRNA levels of
ZO-1, ZO-2, occludin, and claudin-14, all proteins with
barrier strengthening activity (Fig. 3, black bars).
Interestingly, claudin-2 was also significantly downregu-
lated by EPEC. The mRNA levels of claudin-1 were not
significantly affected by EPEC infection, although a trend
towards downregulation was observed compared to un-
treated T-84 control cells. Exposure to OMVs or COF-
SN from either EcN (white bars) or ECOR63 (grey bars)
during infection counteracted the EPEC-induced down-
regulation of occludin and claudin-14, whose expression
levels remained close to those of non-infected control
Fig. 3 Effect of the secreted fractions (COF-SN and OMVs) from EcN
and ECOR63 on the expression of TJ proteins in T-84 monolayers
infected with EPEC. Intestinal epithelial cells were incubated for 3 h
with EPEC at a MOI of 100 (black bars). Parallel infections were
carried out in the presence of COF-SN (0.5 mg/ml) or OMVs (0.1 mg/
ml) from EcN (white bars) or ECOR63 (gray bars). The relative mRNA
levels of the indicated proteins were measured by RT-qPCR using
β-actin as the reference gene. Data are presented as fold-change
compared to untreated control cells (dotted line) from three
independent biological experiments. a, Significance against
untreated control cells (p≤ 0.05); b, significance against EPEC-
infected control cells (p≤ 0.04)
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cells (Fig. 3). Both kinds of samples (OMVs or COF-SN),
regardless of their origin (probiotic or commensal
strains), had similar protective effects on occludin and
claudin-14 expression, as no statistically significant dif-
ferences were observed between them. In contrast, none
of the microbiota secreted fractions could prevent the
negative regulation of ZO-1 and ZO-2 elicited by EPEC.
As expected, the low mRNA levels of claudin-2 in
EPEC-infected cells remained unchanged by OMVs or
COF-SN treatment. These results indicate that secreted
factors released by these gut microbiota strains compen-
sate for the EPEC-triggered negative regulation of occlu-
din and claudin-14 expression, but not that of ZO-1 or
ZO-2. Preservation of both transmembrane TJ proteins
could explain, at least in part, the protection against
EPEC injury observed in TER assays.
EcN and ECOR63 secreted factors trigger redistribution of
ZO-1 and occludin to tight junctions in EPEC-infected
epithelial cells
After EPEC infection, occludin and ZO-1 shift from the
TJ-structures located at the epithelial cell membrane to
intracellular compartments. The altered distribution of
these TJ-proteins greatly contributes to disruption of the
intestinal epithelial barrier induced by this pathogen [12].
To assess whether COF-SN and OMVs from EcN and
ECOR63 could prevent displacement of these proteins in
cells infected with EPEC we carried out an immuno-
fluorescence microscopy analysis in Caco-2 monolayers
(5–7 days after seeding). Cells were incubated with EPEC
(MOI 100) for 3 h as a control for pathogen-mediated
effects, and parallel infections were performed in the
presence of COF-SN or OMVs from EcN and ECOR63.
Then, Caco-2 cells were fixed and stained with specific
antibodies against occludin and ZO-1 (Fig. 4). In cells
infected with EPEC, altered distribution of both proteins
was observed compared to untreated control cells.
The ZO-1 signal was mainly found in the cell boundar-
ies of untreated control Caco-2 monolayers, whereas in
EPEC-infected cells this protein was translocated from the
cell membrane to the cytoplasm. The microbiota secreted
fractions evaluated in this study (COF-SN and OMVs
from EcN and ECOR63) showed a clear potential to
neutralize the EPEC effect, thus retaining the peripheral
location of ZO-1 anchored to the cell membrane.
Regarding occludin, EPEC infection triggered its dis-
sociation from the TJ- structures. The main observation
was discontinuous labelling of occludin in the cell mem-
brane, which indicates disruption of TJs and loss of
intercellular membrane contacts. In addition, a slight in-
crease in the occludin signal in the cytoplasmic com-
partment was detected. When cell monolayers were
infected with the pathogen in the presence of EcN or
ECOR63 secreted fractions, occludin was maintained in
the cell membrane with a staining profile comparable to
that of untreated control cells.
Fluorescence microscopy was also used to analyse F-
actin cytoskeleton alterations. Phalloidin staining re-
vealed a continuous distribution of F-actin at the cell
boundaries of control cells. In contrast, EPEC infection
caused disorganization of the F-actin architecture. The
red-phalloidin fluorescence was dispersed and lost from
peri-junctional areas. As for ZO-1 and occludin, incuba-
tion with OMVs or COF-SN from EcN and ECOR63
partially reversed the EPEC-induced alteration of the F-
actin cytoskeleton. The compensatory effect was most
relevant for the OMVs fractions. The F-actin labelling
pattern clearly differed from that of EPEC-infected cells
and tended to resemble the distribution pattern of the
control group at the intercellular borders (Fig. 5).
Fig. 4 Immunofluorescence staining of ZO-1 and occludin in Caco-2 cell monolayers incubated for 3 h with EPEC in the absence or presence of
COF-SN or OMVs from the indicated bacterial strains. Analysis was performed by laser scanning confocal spectral microscope with 63x oil
immersion objective lens, and images were captured with a Nikon color camera (8 bit). Images shown are representative from three independent
biological experiments and are coded with Fire look-up table. Calibration bar is shown on the left. Scale bar, 20 μm
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Taken together, these results indicate that OMVs and
free-secreted factors released by the probiotic EcN and
the commensal ECOR63 can protect the intestinal epi-
thelium against injury caused by EPEC through mecha-
nisms that include modulation of gene expression and
subcellular redistribution of TJ proteins.
Discussion
Gut microbiota is essential to preserve intestinal homeo-
stasis and human health. A fundamental function of this
microbial community is development and maintenance
of the intestinal barrier. Imbalances in microbiota com-
position may result in increased intestinal permeability,
a condition that is linked to a wide range of illnesses [37,
38]. In the context of gastrointestinal infections, many
studies have investigated the beneficial effects of certain
commensal and probiotic strains in ameliorating intes-
tinal inflammation and injury caused by several enteric
pathogens [39, 40]. Enhancement of gut barrier function
is among the mechanisms used by probiotics to exert
their beneficial effects in the prevention and treatment
of infectious diarrhoea [41]. In fact, certain probiotics
protect intestinal epithelial cells against injury on TJs
caused by various bacterial pathogens [14–17].
It is widely known that EPEC alters intestinal epithelial
TJs, thus leading to epithelial barrier dysfunction and in-
creased permeability [13]. Consistently, this pathogen
causes reduction of TER in monolayers of several epithe-
lial cell lines [11, 16, 25, 42, 43]. EPEC-mediated disrup-
tion of TJs has been extensively studied in several in vitro
and in vivo models. These studies revealed that EPEC per-
turbs interaction between TJ proteins by promoting ZO-1,
occludin, and claudin-1 redistribution from the intercellu-
lar junctions to a cytoplasmic location and disorganizing
the peri-junctional F-actin cytoskeleton [44–46]. Several
bacterial effectors injected into host cells by the T3SS act
synergistically to elicit posttranslational modifications, in-
volving phosphorylation/dephosphorylation mechanisms
and the control of intracellular protein trafficking, that de-
termine the subcellular location of the TJ proteins [12].
Moreover, EPEC also triggers downregulation of genes en-
coding ZO-1, occludin, and claudin-1 in the epithelial cell
line NCM460 [16].
In addition to the barrier strengthening activity of EcN
and ECOR63 secreted fractions (COF-SN and OMVs) on
intact epithelial cell monolayers [31], the results presented
here prove that these extracellular fractions also attenuate
alterations in epithelial barrier function caused by EPEC
infection. The ability of OMVs and COF-SN isolated from
both E. coli strains from human gut microbiota to prevent
the decrease in TER and the increase in paracellular per-
meability in EPEC-infected T-84 and Caco-2 cell mono-
layers reflected their potential to counteract lesions in TJ
integrity induced by this pathogen. The ERK 1/2 signal
transduction pathway is involved in the barrier protective
effect of these microbial factors, as the specific inhibitor
U0126 abolished their ability to reinforce intact epithelial
barrier and neutralized the damage caused by EPEC in
TER assays. However, some differences were observed be-
tween EcN and ECOR63, specifically in the extracellular
fraction that contains free-soluble secreted factors. In the
presence of the ERK inhibitor, the ECOR63 COF-SN frac-
tion still displayed residual barrier protective/strengthen-
ing activity. This suggests that an ECOR63 free-secreted
factor (not released by EcN) can modulate the epithelial
barrier function through other signalling pathway(s). This
observation is consistent with previous results, which
showed that, in addition to free-secreted factors common
Fig. 5 Fluorescence microscopy analysis of F-actin in Caco-2 cell
monolayers incubated for 3 h with EPEC in the absence or presence
of COF-SN or OMVs from the indicated bacterial strains. F-actin was
stained with TRITC-labelled phalloidin (red) and analysis was
performed as described for Fig. 4. Images shown are representative
of three independent biological experiments. Scale bar: 10 μm
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to both strains, ECOR63 releases other soluble factors that
have a great impact on the epithelial barrier. The common
secreted factor that regulates ZO-1 and claudin-14 expres-
sion was TcpC, a protein that is not exported through
extracellular vesicles protein [31]. Proteinase K and heat
treatments of COF-SN fractions confirmed the protein na-
ture of the common active secreted factor (TcpC) and the
presence of other non-proteinic factors in ECOR63 super-
natants. Concerning the active effectors secreted through
OMVs, it should be considered that the ability of EcN and
ECOR63 OMVs to reinforce the epithelial barrier is not a
common feature to all E. coli microbiota strains, as OMVs
from the commensal ECOR12 do not display such activity
[31]. Bacterial vesicles enclose biological components that
exist in the producer bacteria, including a high number of
common microbe-associated molecular patterns, which
are recognized by immune receptors in epithelial and im-
mune cells, and also specific cargo. Therefore, some of the
effects are strain-specific. In this context, proteomic stud-
ies revealed that EcN OMVs enclose specific proteins that
may contribute to gut colonization and modulation of
host responses [47]. Some of these vesicular proteins may
mediate positive modulation on the epithelial barrier al-
though metabolites, small RNAs or lipids cannot be ruled
out. Thus, omics ‘approaches may help to identify the bio-
active factors(s) secreted through OMVs.
To decipher the molecular mechanisms underlying the
protective effects against EPEC infection we undertook
expression and subcellular localization analysis of TJ pro-
teins. Quantitative RT-PCR confirmed downregulation of
ZO-2, ZO-1 and occludin in EPEC-infected intestinal epi-
thelial cells [16, 25], and in addition revealed downregula-
tion of claudin-14. However, we did not observe
significant changes in claudin-1 expression. Interestingly,
the mRNA levels of the leaky protein claudin-2 were di-
minished upon EPEC infection. Thus, unlike other enteric
pathogens such as Salmonella [48], the increased perme-
ability state induced by EPEC does not correlate with high
claudin-2 levels. EcN and ECOR63 secreted fractions pre-
vented EPEC-induced downregulation of occludin and
claudin-14. In contrast, they could not counteract the
EPEC-mediated decrease in ZO-1 or ZO-2 expression. Re-
sults from ZO-1 clearly differ from those reported previ-
ously in cellular models of intact epithelial barrier, which
showed the ability of OMVs and COF-SN to upregulate
ZO-1 expression [31]. This fact suggests that the EPEC-
activated mechanisms responsible for ZO-1 downregula-
tion could not be counteracted by these microbiota extra-
cellular fractions. Although live EcN cells induced ZO-2
expression in T-84 cells [25], the secreted EcN fractions
were unable to exert this positive effect, even under condi-
tions of intact epithelial barrier [31]. These findings sug-
gest that EcN-mediated upregulation of ZO-2 depends on
bacteria-associated factors.
As stated above, the epithelial TJs are highly dynamic
structures whose strength is regulated by multiple stimuli.
Apart from transcriptional regulation [8], TJ proteins are
under the control of posttranslational mechanisms that
modulate their subcellular location and association with
F-actin and other proteins in TJ structures. Reversible
phosphorylation of TJ proteins is a crucial mechanism in
the regulation of the intestinal epithelial barrier, and sev-
eral kinases and phosphatases have been described to act
on TJ proteins [5, 6]. The ability of EcN and ECOR63 se-
creted fractions to counteract delocalization of ZO-1 and
occludin in EPEC-infected cells was confirmed by im-
munofluorescence staining followed by confocal laser
scanning microscopy. For both E.coli microbiota strains,
OMVs and COF-SN fractions protected epithelial mono-
layers against EPEC-induced redistribution of ZO-1 and
occludin, maintaining their association with TJ structures
at the cell boundaries. This suggests their potential to
counteract EPEC-mediated changes in the phosphoryl-
ation state of these TJ proteins. This effect could be medi-
ated, at least in part, by ERK activation, since occludin is a
target substrate of activated ERK [6]. In Caco-2 cells,
ERK-mediated phosphorylation of occludin has posi-
tive barrier effects in preventing TJ disruption by
hydrogen peroxide [49]. The actin cytoskeleton is also
relevant in maintaining TJ structures and modulation
of paracellular solute transport in intestinal epithelial
cells. Immunofluorescence analysis of F-actin revealed
that EPEC-induced alterations in F-actin cytoskeleton
can be partially counteracted by EcN and ECOR63 se-
creted fractions, specially by OMVs. As EPEC disrupts
the peri-junctional actin-myosin ring by activating the
myosin light chain kinase (MLCK) [50], it is likely
that protection exerted by EcN and ECOR63 OMVs
occurs in an MLCK-dependent fashion.
Overall, this study reveals that the protection exerted
by secreted fractions of the probiotic EcN and the com-
mensal ECOR63 against EPEC-mediated disruption of
the epithelial barrier involves compensatory regulation
mechanisms at various levels (Fig. 6), targeted to: (i)
mRNA expression of the TJ proteins occludin and
claudin-14, (ii) redistribution of ZO-1 and occludin from
the cytoplasm to TJ structures at the intercellular con-
tacts and (iii) maintenance of the F-actin cytoskeleton
structure. Considering the in vivo conditions in the hu-
man gut, it should be highlighted that crosstalk between
epithelial and immune cells is crucial for maintaining in-
testinal homeostasis. Therefore, other mechanisms acti-
vated by EcN and ECOR63 secreted factors at the level
of intestinal mucosa could synergistically protect and
reinforce the epithelial barrier. In this context, the ability
of EcN OMVs to upregulate IL-22 and TFF3 in colonic
tissue [32, 33] may magnify the strengthening effects of
the probiotic vesicles on the intestinal epithelial TJs.
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Conclusion
Microbiota-derived vesicles and secreted factors are key
players in inter-species communication in the gut. Now-
adays, the role of gut microbiota extracellular vesicles in
health and disease is an emerging topic as they act as ve-
hicles for the distribution and delivery of many bacterial
effectors to distal tissues. Therefore, their effects are not
restricted to local intestinal environment. This study
broadens our current understanding of how probiotic
and beneficial gut microbes exert their positive effects
on the intestinal epithelial barrier. We show that OMVs
and free-secreted factors by the probiotic EcN and the
commensal ECOR63 can protect the barrier integrity
against EPEC infection by counteracting EPEC-altered
mRNA levels of occludin and claudin-14, maintaining
subcellular localization of ZO-1 and occludin associated
with TJ structures at the cell boundaries, and preserving
F-actin at the inter-cellular junctions.
Methods
Bacterial strains and growth conditions
EcN (serotype O6:K5:H1) is a probiotic E. coli strain, ob-
tained from Ardeypharm (GmbH, Herdecke, Germany).
Strain ECOR63 was isolated from faecal samples col-
lected from a healthy individual [51]. Wild-type EPEC
strain E2348/69 (O127:H6) was kindly provided by B.B.
Finlay. Cultures were grown aerobically at 37 °C in
Luria–Bertani broth (LB) or in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 1% non-
essential amino acids and 25 mM HEPES. Optical dens-
ity at 600 nm (OD600) was used to monitor growth and
calculate the total number of bacterial cells.
Isolation of OMVs and cell-free supernatant fractions
OMVs and cell-free supernatants were obtained as previ-
ously described [31]. Briefly, DMEM cultures of EcN
and ECOR63 were centrifuged (10,000×g, 4 °C, 20 min)
to remove bacterial cells. The supernatants were filtered
through a 0.22 μm pore size filter, concentrated with a
Centricon® Plus-70 filter device and fractionated by
ultracentifugation (150,000×g,1 h at 4 °C) into OMVs
and cell-OMV-free supernatants (COF-SN). OMVs were
washed and suspended in phosphate buffered saline
(PBS). Samples were quantified by protein concentration
[52] and sterility was confirmed by platting one aliquot
on LB plates. Reproducibility of each batch of OMVs
was assessed by negative stain electron microscopy [47].
When indicated COF-SN were subjected to protein-
eliminating treatments. For this, aliquots of COF-SN
were heated at 95 °C for 15 min or incubated with pro-
teinase K (100 μg/ml) for 1 h at 37 °C followed by 30 min
incubation with 0.5 mM phenylmethylsulfonyl fluoride.
Cell culture and infection conditions
T-84 (CCL-248) and Caco-2 (ATCC HTB37) human in-
testinal epithelial cell lines were from the American
Type Culture Collection. Caco-2 cells were grown in
DMEM High Glucose supplemented with 10% (v/v)
foetal bovine serum (FBS) and T-84 cells in DMEM/F12
Glutamax medium with 5% (v/v) FBS. In addition, cul-
ture media contained 25 mM HEPES, 1% non-essential
amino acids, penicillin (100 U/ml) and streptomycin
(100 μg/ml). For propagation, cells were split once a
week. Then, 2 × 105 Caco-2 or T-84 cells were seeded re-
spectively in 55 cm2 dishes or in 75 cm2 flasks.
Fig. 6 Schematic representation of mechanisms used by EPEC to disrupt the intestinal epithelial barrier and their prevention by EcN and ECOR63
secreted fractions (OMVs and soluble free-released factors)
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For infection, EPEC cells grown overnight in LB were
diluted 1:50 with fresh medium and cultured to an
OD600 of 0.5–1.0. Bacterial cells were collected by cen-
trifugation and suspended in serum and antibiotic-free
DMEM plus 0.5% mannose. One hour before infection,
epithelial cells, grown in adequate supports depending
on the experiment, were washed twice in PBS and the
medium was changed to serum and antibiotic-free
medium. EPEC was added to the apical side of epithelial
monolayers at a multiplicity of infection (MOI) of 100
and incubated for 3 h in the absence or presence of
OMVs (0.1 mg/ml) or COF-SN (0.5 mg/ml). When indi-
cated, T-84 cell monolayers were pre-incubated for 15
min with the ERK 1/2 inhibitor U0126 at 25 μM before
the addition of EPEC, OMVs or COF-SNs.
Transepithelial resistance and paracellular marker FD-4
flux measurements
T-84 cells were seeded on the apical compartment of 12
mm polycarbonate Transwell cell culture inserts with a
pore size of 0.4 μm at a cell density of 1 × 105 cells/cm2
and cultured for 9–10 days with medium changes on alter-
nate days. Caco-2 cells were cultured for 18–20 days fol-
lowing the same protocol. Assessment of monolayer
integrity was followed by transepithelial electrical resist-
ance (TER) and microscopic evaluation. TER was mea-
sured as previously reported [31]. EPEC infections were
performed at initial TER values greater than 1000Ω.cm2.
After 3-h infection, cell monolayers were washed with
PBS and kept in serum-free medium containing gentami-
cin 100 μg/ml for 1 h before TER measurement.
Paracellular permeability was evaluated by the flux of
fluorescein isothiocyanate-labelled dextran FD-4 (4 KDa;
Sigma) through differentiated cell monolayers. Prior to the
experiment, monolayer integrity was checked by measuring
TER. Following EPEC infection in the absence or presence
of OMVs or COF-SN, cells were washed twice with PBS
and fresh serum-free medium containing gentamicin
100 μg/ml was added to both Transwell compartments.
Then, FD-4 was added to the apical side at a final concen-
tration of 1mg/ml. Aliquots of 0.1ml were taken from the
basolateral chamber at 0 and 1 h incubation and the fluor-
escence intensity was measured using excitation/emission
wavelengths of 490/510–570 nm in a Modulus™ Microplate
fluorescence reader (Turner BioSystems). For each sample,
FD-4 flux values were calculated by subtracting the inten-
sity fluorescence units measured at 0 h. Data were
expressed as fold-change compared with non-treated con-
trol cells, whose values were normalized as 1.
RNA isolation and quantitative reverse transcription PCR
(RT-qPCR)
T-84 cells were grown in 12 well plates for 9 days. After
3 h infection with EPEC (MOI 100), total RNA was
isolated by the TRIzol method. Concentration and purity
of RNA samples were evaluated by the ratio A260/A280
measured by UV spectrometry. RNA integrity was con-
firmed by electrophoresis on a denaturing 1% agarose/
formaldehyde gel.
For gene expression analysis, cDNA synthesis and RT-
qPCR were performed as described previously [31]. Spe-
cific oligonucleotides for ZO-1, ZO-2, occludin, claudin-
1 and claudin-2 are listed in Table 1. Oligonucleotides
for claudin-14 were from BioRaD (PrimePCR Assay
CLDN14, qHsaCED0023020). The β-actin gene was used
as a reference for normalization. Appropriate control re-
actions were performed in parallel and melting curve
analysis was applied after amplification to exclude un-
specific products. All samples were amplified in tripli-
cates to establish the mean cycle threshold value (ct).
Relative changes in gene expression versus untreated
control cells were calculated applying the ΔΔCt formula.
Immunofluorescence labelling and confocal microscopy
analysis
Caco-2 cells were grown in an 8-well chamber slide (Ibidi)
for 6 days. After EPEC infection in the absence or presence
of COF-SN or OMVs, cells were washed, fixed and perme-
abilized as described before [31]. Nuclei were labelled with
DAPI (0.125 μg/ml), and occludin and ZO-1 were stained
respectively with anti-occludin mouse IgG antibody
(0.5 μg/ml, Invitrogen) and anti-ZO-1 rabbit IgG antibody
(5 μg/ml, Invitrogen) [31]. F-actin was stained with phal-
loidin–tetramethylrhodamine B isothiocyanate (−TRITC)
(dilution 1:50) as described previously [56]. Immunofluor-
escence was analysed in a Leica TCS SP2 confocal micro-
scope with a 63 × 1.32NA oil immersion objective and Ar,
Ar-UV and HeNe lasers. Fluorescence was recorded at
405 nm (blue; DAPI) and at 488 nm (green, Alexa Fluor
488). Images (12-bit) were obtained at a resolution of
0.232 × 0.232 × 0.488 μm/voxel (x, y, z respectively) and
analysed using Fiji processing package [57].
Table 1 Primer sequences used for RT-qPCR
Genes Primer sequences References
ZO-1 Fw: 5′-CGGGACTGTTGGTATTGGCTAGA-3′
Rv: 5′-GGCCAGGGCCATAGTAAGTTG-3′
[53]
ZO-2 Fw: 5′-CTAGCAGCGATCAACTTAGGGACAA-3′
Rv: 5′-CCCAGGAGTTTCATTACCAGCAA-3′
[53]
occludin Fw: 5′- TCCTATAAATCCACGCCGGTTC − 3′
Rv: 5′- CTAAAGTTACCACCGCTGCTG − 3′
[53]
Claudin-1 Fw: 5′-GCCCCAGTGGAGGATTTACT-3′
Rv: 5′-GTTTTGGATAGGGCCTTGGT-3′
[54]
Claudin-2 Fw: 5′-ACCTGCTACCGCCACTCTGT-3′
Rv: 5′- CTCCCTGGCCTGCATTATCTC-3′
[48]
β-actin Fw: 5′-GCTCTGGCTCCTAGCACCAT-3′
Rv: 5′-GCCACCGATCCACACAGAGT-3′
[55]
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Statistical analysis
The SPSS software package (version 20.0, Chicago, IL,
USA) was used for statistical analysis. Data were col-
lected from at least three independent biological ex-
periments and values are presented as the mean ±
standard error (SE). The one-way ANOVA followed
by Tukey’s post-test was used to assess whether dif-
ferences between more than two groups were statisti-
cally significant (p-value ≤0.05).
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